Anti-acetylcholinesterase activity and antioxidant properties of extracts and fractions of Carpolobia lutea

References

• Adams M, Gmünder F, Hamburger M. 2007. Plants traditionally used in age related brain disorders— a survey of ethnobotanical literature. J Ethnopharmacol. 113:363–381.
   PubMed Web of Science ®Google Scholar
• Ajiwhen IO, Bisong SA. 2013. Effect of ethanolic extract of Carpolobia lutea G. Don (Polygalaceae) root on learning and memory in CD1 mice. Niger J Physiol Sci. 28:141–145.
   PubMedGoogle Scholar
• Akhondzadeh S, Abbasi SH. 2006. Herbal medicine in the treatment of Alzheimer's disease. Am J Alzheimers Dis Other Demen. 21:113–118.
   PubMedGoogle Scholar
• Alzheimer’s Disease International. 2015. World Alzheimer Report 2015: The Global Impact of Dementia. [accessed 2016 Oct 4]. http://www.alz.co.uk/research/world-report-2015.
   Google Scholar
• Anekonda TS, Reddy PH. 2005. Can herbs provide a new generation of drugs for treating Alzheimer's disease? Brain Res Brain Res Rev. 50:361–376.
   PubMed Web of Science ®Google Scholar
• Ansari N, Khodagholi F. 2013. Natural products as promising drug candidates for the treatment of Alzheimer's disease: molecular mechanism aspect. Curr Neuropharmacol. 11:414–429.
   PubMed Web of Science ®Google Scholar
• Ashani Y, Peggins JO, Doctor BP. 1992. Mechanism of inhibition of cholinesterases by huperzine A. Biochem Biophys Res Commun. 184:719–726.
   PubMed Web of Science ®Google Scholar
• Ballard C, Gauthier S, Corbett A, Brayne C, Aarsland D, Jones E. 2011. Alzheimer's disease. Lancet. 377:1019–1031.
   PubMed Web of Science ®Google Scholar
• Calderón AI, Cubilla M, Espinosa A, Gupta MP. 2010. Screening of plants of Amaryllidaceae and related families from Panama as sources of acetylcholinesterase inhibitors. Pharm Biol. 48:988–993.
   PubMed Web of Science ®Google Scholar
• Carter WG, Tarhoni M, Rathbone AJ, Ray DE. 2007. Differential protein adduction by seven organophosphorus pesticides in both brain and thymus. Hum Exp Toxicol. 26:347–353.
   PubMed Web of Science ®Google Scholar
• Duysen EG, Li B, Darvesh S, Lockridge O. 2007. Sensitivity of butyrylcholinesterase knockout mice to (−)-huperzine A and donepezil suggests humans with butyrylcholinesterase deficiency may not tolerate these Alzheimer's disease drugs and indicates butyrylcholinesterase function in neurotransmission. Toxicology. 233:60–69.
   PubMed Web of Science ®Google Scholar
• Ellman GL, Courtney KD, Andres V, Featherstone RM. 1961. A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem Pharmacol. 7:88–95.
   PubMed Web of Science ®Google Scholar
• Global Health and Aging report. 2011. World Health Organization. [accessed 2016 Oct 4]. www.who.int/ageing/publications/global_health.pdf.
   Google Scholar
• Gurib-Fakim A. 2006. Medicinal plants: traditions of yesterday and drugs of tomorrow. Mol Aspects Med. 27:1–93.
   PubMedGoogle Scholar
• Hajiaghaee R, Akhondzadeh S. 2012. Herbal medicine in the treatment of Alzheimer’s disease. J Med Plants. 11:41.
   Google Scholar
• Hlila MB, Omri A, Jannet HB, Lamari A, Aouni M, Selmi B. 2013. Phenolic composition, antioxidant and anti-acetylcholinesterase activities of the Tunisian Scabiosa arenaria. Pharm Biol. 51:525–532.
   PubMed Web of Science ®Google Scholar
• Howes M-JR, Houghton PJ. 2003. Plants used in Chinese and Indian traditional medicine for improvement of memory and cognitive function. Pharmacol Biochem Behav. 75:513–527.
   PubMed Web of Science ®Google Scholar
• Lockridge O. 2015. Review of human butyrylcholinesterase structure, function, genetic variants, history of use in the clinic, and potential therapeutic uses. Pharmacol Ther. 148:34–46.
   PubMed Web of Science ®Google Scholar
• Manoharan I, Boopathy R, Darvesh S, Lockridge O. 2007. A medical health report on individuals with silent butyrylcholinesterase in the Vysya community of India. Clin Chim Acta. 378:128–135.
   PubMed Web of Science ®Google Scholar
• Menon JS, Krishnakumar K, Dineshkumar B, John A, Paul D, Cherian J. 2013. Herbs for Alzheimer disease – a review. Int J Res Plant Sci. 3:54–56.
   Google Scholar
• Mesulam MM, Guillozet A, Shaw P, Levey A, Duysen EG, Lockridge O. 2002. Acetylcholinesterase knockouts establish central cholinergic pathways and can use butyrylcholinesterase to hydrolyze acetylcholine. Neuroscience. 110:627–639.
   PubMed Web of Science ®Google Scholar
• Mufson EJ, Counts SE, Perez SE, Ginsberg SD. 2008. Cholinergic system during the progression of Alzheimer's disease: therapeutic implications. Expert Rev Neurother. 8:1703–1718.
   PubMedGoogle Scholar
• Mukherjee PK, Kumar V, Mal M, Houghton PJ. 2007. Acetylcholinesterase inhibitors from plants. Pytomedicine. 14:289–300.
   PubMed Web of Science ®Google Scholar
• Muñoz-Torrero D. 2008. Acetylcholinesterase inhibitors as disease-modifying therapies for Alzheimer's disease. Curr Med Chem. 15:2433–2455.
   PubMed Web of Science ®Google Scholar
• Natarajan S, Shunmugiah KP, Kasi PD. 2013. Plants traditionally used in age-related brain disorders (dementia): an ethanopharmacological survey. Pharm Biol. 51:492–523.
   PubMed Web of Science ®Google Scholar
• Nwidu LL, Aprioku JS, Guluye FH. 2014. Study on radical scavenging and gastroprotective effects of ethanolic stem-bark extract of Carbolobia lutea in rodents. W J Pharm Res. 3:73–88.
   Google Scholar
• Nwidu LL, Cilli EM, Vilegas W. 2012. Amino acid, antioxidant and ion profiles of Carpolobia lutea leaf (Polygalaceae). Trop J Pharm Res. 11:807–813.
   Web of Science ®Google Scholar
• Nwidu LL, Essien GE, Nwafor PA, Vilegas W. 2011. Antidiarrheal mechanism of Carpolobia lutea leaf fractions in rats. Pharm Biol. 49:1249–1256.
   PubMed Web of Science ®Google Scholar
• Nwidu LL, Nwafor PA, da Silva VC, Rodrigues CM, dos Santos LC, Vilegas W, Nunes-de-Souza RL. 2011. Anti-nociceptive effects of Carpolobia lutea G. Don (Polygalaceae) leaf fractions in animal models. Inflammopharmacology. 19:215–225.
   PubMedGoogle Scholar
• Orhan IE. 2013. Nature: a substantial source of auspicious substances with acetylcholinesterase inhibitory action. Curr Neuropharmacol. 11:379–387.
   PubMed Web of Science ®Google Scholar
• Parihar MS, Hemnani T. 2004. Alzheimer's disease pathogenesis and therapeutic interventions. J Clin Neurosci. 11:456–467.
   PubMed Web of Science ®Google Scholar
• Pinho BR, Ferreres F, Valentão P, Andrade PB. 2013. Nature as a source of metabolites with cholinesterase-inhibitory activity: an approach to Alzheimer's disease treatment. J Pharm Pharmacol. 65:1681–1700.
   PubMed Web of Science ®Google Scholar
• Seltzer B. 2006. Cholinesterase inhibitors in the clinical management of Alzheimer's disease: importance of early and persistent treatment. J Int Med Res. 34:339–347.
   PubMed Web of Science ®Google Scholar
• Şenol FS, Yilmaz G, Şener B, Koyuncu M, Orhan I. 2010. Preliminary screening of acetylcholinesterase inhibitory and antioxidant activities of Anatolian Heptaptera species. Pharm Biol. 48:337–341.
   PubMed Web of Science ®Google Scholar
• Shakir T, Coulibaly AY, Kehoe PG. 2013. An exploration of the potential mechanisms and translational potential of five medicinal plants for applications in Alzheimer's disease. Am J Neurodegener Dis. 2:70–88.
   PubMedGoogle Scholar
• Shiksharthi AN, Mittal S, Ramana J. 2011. Systematic review of herbals as potential memory enhancers. Int J Res Pharm Biomed Sci. 2:918–925.
   Google Scholar
• Sun X, Jin L, Ling P. 2012. Review of drugs for Alzheimer's disease. Drug Discov Ther. 6:285–290.
   PubMedGoogle Scholar
• Syad AN, Devi KP. 2014. Botanics: a potential source of new therapies for Alzheimer’s disease. Botanics: Targets Therapy. 4:11–26.
   Google Scholar
• Tarhoni MH, Vigneswara V, Smith M, Anderson S, Wigmore P, Lees J, Ray DE, Carter WG. 2011. Detection, quantification, and microlocalisation of targets of pesticides using microchannel plate autoradiographic imagers. Molecules. 16:8535–8551.
   PubMed Web of Science ®Google Scholar
• Thomsen T, Kaden B, Fischer JP, Bickel U, Barz H, Gusztony G, Cervos-Navarro J, Kewitz H. 1991. Inhibition of acetylcholinesterase activity in human brain tissue and erythrocytes by galanthamine, physostigmine and tacrine. Eur J Clin Chem Clin Biochem. 29:487–492.
   PubMedGoogle Scholar
• Triggle DJ, Mitchell JM, Filler R. 1998. The pharmacology of physostigmine. CNS Drug Rev. 4:87–136.
   Google Scholar
• Tundis R, Bonesi M, Menichini F, Loizzo MR. 2016. Recent knowledge on medicinal plants as source of cholinesterase inhibitors for the treatment of dementia. Mini Rev Med Chem. 16:605–618.
   PubMed Web of Science ®Google Scholar
• Uriarte-Pueyo I, Calvo MI. 2011. Flavonoids as acetylcholinesterase inhibitors. Curr Med Chem. 18:5289–5302.
   PubMed Web of Science ®Google Scholar
• Zhao Y, Zhao B. 2013. Oxidative stress and the pathogenesis of Alzheimer's disease. Oxid Med Cell Longev. 2013:316523.
   PubMed Web of Science ®Google Scholar